|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 432.40 INR | -0.08% |
|
-3.63% | -2.03% |
| 05-23 | Unichem Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 | CI |
| 05-22 | Unichem Laboratories March-quarter consol profit 109.1 million rupees | RE |
| Market Cap | 20.68B 219M 193M 178M 166M 311M 318M 2.13B 826M 10.21B 824M 806M 35.48B | P/E 2024 |
-48.8x | P/E 2025 | 35.6x |
|---|---|---|---|---|---|
| Enterprise Value | 24.38B 259M 227M 209M 196M 367M 375M 2.51B 974M 12.04B 971M 950M 41.83B | EV / Sales 2024 |
2.07x | EV / Sales 2025 | 2.49x |
| Free-Float |
28.71% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -0.08% | ||
| 1 week | -3.63% | ||
| Current month | +23.53% | ||
| 1 month | +19.56% | ||
| 3 months | +44.59% | ||
| 6 months | -2.97% | ||
| Current year | -2.03% |
| 1 week | 424.6 |  | 457.15 |
| 1 month | 339 | | 515.55 |
| Current year | 280 | | 515.55 |
| 1 year | 280 | | 656.85 |
| 3 years | 280 | | 949.85 |
| 5 years | 197.5 | | 949.85 |
| 10 years | 75.1 | | 949.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 10/08/2023 | |
Sanjay Jain
DFI | Director of Finance/CFO | - | 08/08/2024 |
Dhananjay Sathe
CMP | Compliance Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 22/08/1977 | |
Pranay Godha
BRD | Director/Board Member | 53 | 10/08/2023 |
| Director/Board Member | 57 | 10/08/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.08% | -3.63% | -27.81% | +16.69% | 323M | |
| +7.13% | +9.97% | +52.48% | +163.30% | 1,006B | |
| +3.99% | +11.50% | +67.23% | +53.89% | 589B | |
| +4.20% | +17.03% | +36.66% | +86.40% | 430B | |
| +0.99% | +5.11% | +29.26% | +21.27% | 331B | |
| +1.82% | +8.85% | +39.72% | +25.35% | 288B | |
| +0.22% | +6.98% | +32.93% | +39.24% | 285B | |
| +0.73% | +13.51% | -26.95% | -41.57% | 213B | |
| +1.56% | +6.14% | +27.82% | +57.78% | 190B | |
| +3.26% | +3.33% | +20.72% | +65.07% | 154B | |
| Average | +0.88% | +5.00% | +25.20% | +48.74% | 348.61B | |
| Weighted average by Cap. | +0.65% | +5.38% | +40.56% | +77.67% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 17.05B 181M 159M 146M 137M 257M 262M 1.76B 681M 8.42B 679M 664M 29.25B | 21.11B 224M 197M 181M 170M 318M 325M 2.18B 843M 10.42B 841M 822M 36.22B |
| Net income | -705M -7.47M -6.56M -6.05M -5.66M -10.61M -10.84M -72.68M -28.14M -348M -28.06M -27.45M -1.21B | 1.38B 14.58M 12.81M 11.8M 11.05M 20.7M 21.14M 142M 54.91M 679M 54.76M 53.56M 2.36B |
| Net Debt | 953M 10.1M 8.87M 8.18M 7.65M 14.34M 14.65M 98.25M 38.04M 470M 37.94M 37.1M 1.63B | 3.7B 39.25M 34.47M 31.78M 29.74M 55.72M 56.92M 382M 148M 1.83B 147M 144M 6.35B |
Employees
3,142
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 25/06/26 | ₹432.40 | -0.08% | 4,025 |
| 24/06/26 | ₹432.75 | -0.75% | 1,609 |
| 23/06/26 | ₹436.00 | -2.69% | 7,352 |
| 22/06/26 | ₹448.05 | +0.55% | 3,140 |
| 19/06/26 | ₹445.60 | -0.69% | 9,052 |
- Stock Market
- Stocks
- UNICHEMLAB Stock
Select your edition
All financial news and data tailored to specific country editions
